ACADIA Pharmaceuticals (ACAD) Stock: Gaining on NUPLAZID Launch

By |May 31st, 2016|

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD)

ACADIA Pharmaceuticals is having a strong day in the market today, and for good reason. The company has announced the launch of a newly approved treatment in the United States. Today, we’ll talk about the announcement, how the market reacted to the news, and what we can expect to see […]